SR9009 Stenabolic SARMS-Powder CAS 1379686-30-2 Lingding302

Boiling point  547.2±45.0 °C(Predicted)
density  1.327±0.06 g/cm3(Predicted)
pka  6.12±0.50(Predicted)


Application & Function

SR-9009 is an agonist at nuclear receptor Rev-ErbA. Greatly diminishes VILI-induced lung edema, inflammatory cell infiltration and TNFα production in a rat lung injury model. SR-9009 suppresses atherosclerosis in a mouse model. Specifically lethal to cancer cells and oncogene-induced senescent cells with no effect on the viability of normal cells or tissues. Disrupts pain associated with osteoarthritis by reducing BMAL1 expression in bmal1f/fNav1.8CreERT mice.


Fat Loss

  • Increases glucose metabolism
  • Increases calorie metabolism
  • Improves basal metabolic rate
  • Reduced Inflammation
  • Treatment for Obesity,Type II Diabetes,sarcopenia,Cholesterol-Related Conditions

Package & Trade Terms

Package: 25kg carton drum (32cm*58cm)or 1kg foil bag (10cm*15cm) or by request of clients

Storage Condition: 2-8°C

Supply Ability: 10000.00KG/Month

Trade Terms: FOB,CIF,CIP,EXW

Shipping Mode: By Sea,By Air

Shipping Port: Tianjin

Payment Terms: T/T,Western Union